Clinical Trial Update: Study of AA4500 in the Treatment of Peyronie's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial of AA4500 for Peyronie's disease completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peyronie Disease

Drugs mentioned

• AA4500

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Peyronie's Disease | Phase 3 | Status: COMPLETED | Results posted: 2015-04-07